Wonmont 4 Oral Suspension Delicious Orange contains Montelukast sodium at a concentration of 4 mg per 5 ml, formulated as a palatable orange-flavored liquid to facilitate administration in pediatric patients. Montelukast is a leukotriene receptor antagonist that selectively inhibits the cysteinyl leukotriene receptor CysLT1, thereby preventing the action of leukotrienes involved in the pathophysiology of asthma and allergic rhinitis. This medication is indicated for the prophylaxis and chronic treatment of asthma in children aged 2 years and older, helping to reduce the frequency and severity of asthma attacks. Additionally, Wonmont 4 Oral Suspension is effective in managing symptoms of seasonal allergic rhinitis, including nasal congestion, sneezing, and rhinorrhea. The oral suspension form is particularly advantageous for patients who have difficulty swallowing tablets. Dosage should be individualized based on the patient’s age and clinical response, and it is essential to adhere to prescribed regimens for optimal therapeutic outcomes. Common adverse effects may include headache, abdominal pain, and upper respiratory tract infections, though the medication is generally well tolerated. Patients should be monitored for any hypersensitivity reactions or neuropsychiatric events, and healthcare providers should evaluate the ongoing need for treatment periodically.